China's Leading Device Maker Mindray Projects Strong Earnings Despite Instability Across The Middle East
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Despite instability in the Middle East and North Africa, the leadership of Mindray Medical International is pressing ahead with plans to expand sales in international markets and is projecting a rise in net earnings of more than 10% in 2011
You may also be interested in...
Reimbursement Expansion To Fuel China Device Growth In 2011 (Part 2 of 2)
[Editor's note: This is part two of a two-part story. Part one appeared in PharmAsia News, Feb. 22, 2011.]
Reimbursement Expansion To Fuel China Device Growth In 2011 (Part 2 of 2)
[Editor's note: This is part two of a two-part story. Part one appeared in PharmAsia News, Feb. 22, 2011.]
Pharmas Assess Impact In Egypt; Local Player Hikma Less Exposed, Say Analysts
As drug makers restart their Egyptian operations, financial analysts have begun to assess the impact of recent events for the pharma industry. As the largest pharma market in the Middle East, Egypt has attracted both multinational and local drug makers, but local firms such as leading Jordanian pharma Hikma may see less disruption from political events than MNC counterparts, according to Credit Suisse analysts